Effect of tegaserod on recto-sigmoid tonic and phasic activity in constipation-predominant irritable bowel syndrome

American Journal of Gastroenterology

Volumn 102, Issue 8, 2007, Pages 1720-1726

  Di Stefano, Michele ^a   Miceli, Emanuela ^a   Mazzocchi, Samanta ^a   Tana, Paola ^a   Missanelli, Antonio ^a   Corazza, Gino R ^a  

^a UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TEGASEROD;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONSTIPATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; FEMALE; HUMAN; INTESTINE CONTRACTION; INTESTINE INNERVATION; IRRITABLE COLON; PRIORITY JOURNAL; TREATMENT RESPONSE;

ADULT; COLON, SIGMOID; CONSTIPATION; FEMALE; HUMANS; INDOLES; IRRITABLE BOWEL SYNDROME; MIDDLE AGED; MUSCLE TONUS; RECTUM; SEROTONIN AGONISTS;

EID: 34547614263     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01336.x     Document Type: Article

References (31)

1. Camilleri M, Choi MG. Review article: Irritable bowel syndrome. Aliment Pharmacol Ther 1997 11 : 3 15.
2. Spiller R. Serotonergic modulating drugs for functional gastrointestinal disease. Br J Clin Pharmacol 2002 54 : 11 20.
3. Tonini M, De Ponti F. Serotonin modulation of gastrointestinal motility. In : Gaginella TS, Galligan JJ eds. Serotonin and gastrointestinal function. Boca Raton, FL : CRC Press, 1995 : 53 84.
4. Camilleri M. Management of the irritable bowel syndrome. Gastroenterology 2001 120 : 652 68.
5. Clayton NM, Sargent R, Butler A, et al. The pharmacological properties of the novel selective 5-HT3 receptor antagonist, alosetron, and its effects on normal and perturbed small intestinal transit in the fasted rat. Neurogastroenterol Motil 1999 11 : 207 17.
6. Bush TG, Spencer NJ, Watters N, et al. Effects of alosetron on spontaneous migrating motor complexes in murine small and large bowel in vitro. Am J Physiol Gastrointest Liver Physiol 2001 281 : G974 83.
7. Camilleri M, Northcutt AR, Kong S, et al. Efficacy and safety of alosetron in women with irritable bowel syndrome: A randomized, placebo-controlled trial. Lancet 2000 355 : 1035 40.
8. Lembo T, Wright RA, Bagby B, et al. Alosetron controls bowel urgency and provides global symptom improvement in women with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 2001 96 : 2662 70.
9. Camilleri M, Mayer EA, Drossman DA, et al. Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5HT3-receptor antagonist. Aliment Pharmacol Ther 1999 13 : 1149 59.
10. Di Stefano M, Vos R, Janssens J, et al. Effect of tegaserod, a 5HT4 receptor partial agonist, on interdigestive and postprandial gastrointestinal motility in healthy volunteers. Gastroenterology 2003 124 : S1148.
11. Tack J, Müller-Lissner S, Bytzer P, et al. A randomized controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation. Gut 2005 54 : 1707 13.
12. Kamm MA, Muller-Lissner S, Talley NJ, et al. Tegaserod for the treatment of chronic constipation: A randomized, double-blind, placebo-controlled multinational study. Am J Gastroenterol 2005 100 : 362 72.
13. Novick J, Miner P, Krause R, et al. A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2002 16 : 1877 88.
14. Muller-Lissner SA, Fumagalli I, Bardhan KD, et al. Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 2001 15 : 1655 66.
15. Prather CM, Camilleri M, Zinsmeister AR, et al. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome Gastroenterology 2000 118 : 463 8.
16. Di Stefano M, Miceli E, Missanelli A, et al. Meal-induced recto-sigmoid tone modification: A low-caloric meal accurately separates functional and organic gastrointestinal disease patients. Gut 2006 55 : 1409 14.
17. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorder and functional abdominal pain. Gut 1999 45 (Suppl II II43 7.
18. Bell AM, Pemberton JH, Hanson RB, et al. Variations in muscle tone of the human rectum: Recordings with an electromechanical barostat. Am J Physiol Gastrointest Liver Physiol 1991 23 : G17 25.
19. Azpiroz F, Malagelda JR. Gastric tone measured by an electronic barostat in health and postsurgical gastroparesis. Gastroenterology 1987 92 : 934 43.
20. Derogatis L. The SCL-90-R manual-II: Scoring, administration and procedures for the SCL-90-R, 2nd Ed. Towson, MD : Clinical Psycometric Research, 1992.
21. Maes BD, Ghoos YF, Hiele MI, et al. Gastric emptying rate of solids in patients with nonulcer dyspepsia. Dig Dis Sci 1997 42 : 1158 62.
22. Kellow JE, Phillips SF. Altered small bowel motility in irritable bowel syndrome is correlated with symptoms. Gastroenterology 1987 92 : 1885 93.
23. Talley NJ. Serotoninergic neuroenteric neuromodulators. Lancet 2001 358 : 2061 8.
24. Grider JR, Foxx-Orenstein AE, Jin JG. 5-Hydroxytryptamine 4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine. Gastroenterology 1998 115 : 370 80.
25. Tack J, Broekaert D, Corsetti M, et al. Influence of acute serotonin reuptake inhibition on colonic sensorimotor function in man. Aliment Pharmacol Ther 2006 23 : 265 74.
26. Halls J. Bowel content shift during normal defaecation. Proc R Soc Med 1965 58 : 859 60.
27. Lubowski DZ, Meagher AP, Smart RC, et al. Scintigraphic assessment of colonic function during defaecation. Int J Colorectal Dis 1995 10 : 91 3.
28. Bampton PA, Dinning PG, Kennedy ML, et al. Spatial and temporal organization of pressure patterns throughout the unprepared colon during spontaneous defecation. Am J Gastroenterol 2000 95 : 1027 35.
29. Christensen J. Motility of the colon. In : Johnson LR, ed. Physiology of the gastrointestinal tract, 2nd Ed. New York : Raven, 1987 : 665 93.
30. Pitz M, Cheang M, Bernstein CN. Defining the predictors of the placebo response in irritable bowel syndrome. Clin Gastroenterol Hepatol 2005 3 : 237 47.
31. Tremolaterra F, Serra J, Azpiroz F, et al. Intestinal tone and gas motion. Neurogastroenterol Motil 2003 15 : 581.